Kristina Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kristina Zhang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Flavia Venetucci Gouveia
Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, Ontario, Canada
3 shared publications - George M. Ibrahim
Division of Neurosurgery The Hospital for Sick Children Toronto Ontario Canada
3 shared publications - Alfonso Fasano
Department of Biomedical Sciences Humanitas University Milan Italy
1 shared publication - Brian J. Nieman
Mouse Imaging Centre, The Hospital for Sick Children, Toronto, ON M5T 3H7, Canada
1 shared publication - Carolina Gorodetsky
Division of Neurology, the Hospital for Sick Children, Toronto, Ontario, Canada
1 shared publication - Hrishikesh Suresh
Neurosciences and Mental Health, Hospital for Sick Children, Toronto, Ontario, Canada
1 shared publication
Latest Publications
- Open Access
- 10 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (15) , eaeb5842
Regulation of autism-related self-injurious behavior by electrical stimulation of corticostriatal circuits in mice and humans
Dysfunction of corticostriatal circuitry is related to the emergence of self-injurious behavior (SIB) in autism spectrum disorder (ASD). Despite mounting interest in circuit-based interventions for severe, refractory SIB, the lack of causal evidence linking modulation of corticostriatal networks to changes in SIB has limited the advancement of effective, targeted therapies. In this study, we demonstrate that electrical stimulation of the nucleus accumbens (NAcc) mitigates SIB and induces structural changes along corticostriatal circuits in a mouse model relevant for ASD and children with severe SIB undergoing NAcc-targeted deep brain stimulation. In BTBR T + Itpr3 tf /J mice, NAcc stimulation selectively reduced injurious self-grooming—a behavioral metric of SIB—and led to morphological changes in corticostriatal networks. In children with severe SIB, electric stimulation at a locus of optimal therapeutic response within the NAcc engaged widespread sensorimotor, limbic, and striatal networks and induced longitudinal structural changes in fronto-limbic-striatal brain regions. These findings highlight the role of the fronto-limbic-striatal network in SIB regulation and support corticostriatal neuromodulation as a mechanistic therapy for these extreme behaviors.
- 10 April 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (15) , eaeb5842
Open AccessRegulation of autism-related self-injurious behavior by electrical stimulation of corticostriatal circuits in mice and humans
Dysfunction of corticostriatal circuitry is related to the emergence of self-injurious behavior (SIB) in autism spectrum disorder (ASD). Despite mounting interest in circuit-based interventions for severe, refractory SIB, the lack of causal evidence linking modulation of corticostriatal networks to changes in SIB has limited the advancement of effective, targeted therapies. In this study, we demonstrate that electrical stimulation of the nucleus accumbens (NAcc) mitigates SIB and induces structural changes along corticostriatal circuits in a mouse model relevant for ASD and children with severe SIB undergoing NAcc-targeted deep brain stimulation. In BTBR T + Itpr3 tf /J mice, NAcc stimulation selectively reduced injurious self-grooming—a behavioral metric of SIB—and led to morphological changes in corticostriatal networks. In children with severe SIB, electric stimulation at a locus of optimal therapeutic response within the NAcc engaged widespread sensorimotor, limbic, and striatal networks and induced longitudinal structural changes in fronto-limbic-striatal brain regions. These findings highlight the role of the fronto-limbic-striatal network in SIB regulation and support corticostriatal neuromodulation as a mechanistic therapy for these extreme behaviors.
- 24 July 2025
- Published by Elsevier in Experimental Neurology
- Vol. 393, 115394
Effects of centromedian thalamic deep brain stimulation on striatal glutamate and GABA in a rodent model of epilepsy
- 24 July 2025
- Published by Elsevier in Experimental Neurology
- Vol. 393, 115394
Effects of centromedian thalamic deep brain stimulation on striatal glutamate and GABA in a rodent model of epilepsy
- Open Access
- 24 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1938
Molecular Pathways, Neural Circuits and Emerging Therapies for Self-Injurious Behaviour
Nonsuicidal self-injurious behaviour (SIB) is a debilitating manifestation of physical aggression commonly observed across neurodevelopmental, psychiatric, and genetic disorders. This behaviour arises from a multifactorial aetiology involving genetic predispositions, epigenetic modifications, neurotransmitter dysregulation, and environmental stressors. Dysregulation in dopaminergic, serotonergic, glutamatergic, and GABAergic systems has been implicated in the pathophysiology of SIB, alongside structural and functional abnormalities within fronto-limbic-striatal circuits. These disruptions impair key processes, such as emotional regulation, reward processing, and behavioural inhibition, contributing to the emergence and reinforcement of SIB. Advances in preclinical research using genetic, lesion-based, pharmacological, and environmental animal models have been instrumental in elucidating the molecular and neurocircuitry underpinnings of SIB. Emerging neuromodulation therapies targeting critical nodes within the fronto-limbic-striatal network, particularly deep brain stimulation, have shown promise in treating severe, refractory SIB and improving quality of life. This review integrates current evidence from clinical studies, molecular research, and preclinical models to provide a comprehensive overview of the pathophysiology of SIB and therapeutic approaches. By focusing on the molecular mechanisms and neural circuits underlying SIB, we highlight the translational potential of emerging pharmacological and neuromodulatory therapies. A deeper understanding of these pathways will pave the way for precision-based interventions, bridging the gap between molecular research and clinical applications in SIB and related conditions.
- 24 February 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (5) , 1938
Open AccessMolecular Pathways, Neural Circuits and Emerging Therapies for Self-Injurious Behaviour
Nonsuicidal self-injurious behaviour (SIB) is a debilitating manifestation of physical aggression commonly observed across neurodevelopmental, psychiatric, and genetic disorders. This behaviour arises from a multifactorial aetiology involving genetic predispositions, epigenetic modifications, neurotransmitter dysregulation, and environmental stressors. Dysregulation in dopaminergic, serotonergic, glutamatergic, and GABAergic systems has been implicated in the pathophysiology of SIB, alongside structural and functional abnormalities within fronto-limbic-striatal circuits. These disruptions impair key processes, such as emotional regulation, reward processing, and behavioural inhibition, contributing to the emergence and reinforcement of SIB. Advances in preclinical research using genetic, lesion-based, pharmacological, and environmental animal models have been instrumental in elucidating the molecular and neurocircuitry underpinnings of SIB. Emerging neuromodulation therapies targeting critical nodes within the fronto-limbic-striatal network, particularly deep brain stimulation, have shown promise in treating severe, refractory SIB and improving quality of life. This review integrates current evidence from clinical studies, molecular research, and preclinical models to provide a comprehensive overview of the pathophysiology of SIB and therapeutic approaches. By focusing on the molecular mechanisms and neural circuits underlying SIB, we highlight the translational potential of emerging pharmacological and neuromodulatory therapies. A deeper understanding of these pathways will pave the way for precision-based interventions, bridging the gap between molecular research and clinical applications in SIB and related conditions.